Marginal recurrences after selective targeting with intensity-modulated radiotherapy for oral tongue cancer

Head and Neck

Volumn 34, Issue 6, 2012, Pages 900-906

  Damast, Shari ^a   Wolden, Suzanne ^a   Lee, Nancy ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

head and neck cancer; intensity modulated radiation therapy; oral cavity cancer; quality assurance; target volume delineation

Indexed keywords

CETUXIMAB; CISPLATIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; PRIORITY JOURNAL; TONGUE CANCER; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; FEMALE; GLOSSECTOMY; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; TONGUE NEOPLASMS;

EID: 84861331852     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21677     Document Type: Article

References (33)

1. Rusthoven K, Ballonoff A, Raben D, Chen C,. Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma. Cancer 2008; 112: 345-351.
2. Huang SF, Kang CJ, Lin CY, et al. Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection. Cancer 2008; 112: 1066-1075.
3. Kowalski LP,. Results of salvage treatment of the neck in patients with oral cancer. Arch Otolaryngol Head Neck Surg 2002; 128: 58-62.
4. Spaulding CA, Korb LJ, Constable WC, Cantrell RW, Levine PA,. The influence of extent of neck treatment upon control of cervical lymphadenopathy in cancers of the oral tongue. Int J Radiat Oncol Biol Phys 1991; 21: 577-581.
5. Million RR, Cassisi NJ,. Oral Cavity. In:, Million RR, Cassissi NJ, editors. Management of head and neck cancer: a multidisciplinary approach. Philadelphia: J.B. Lippincott Company; 1984. pp 239-297.
6. Eisbruch A, Gregoire V,. Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer. Semin Radiat Oncol 2009; 19: 43-52.
7. Mendenhall WM, Amdur RJ, Palta JR,. Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol 2006; 24: 2618-2623.
8. Gomez DR, Zhung JE, Gomez J, et al. Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys 2009; 73: 1096-1103.
9. Chao KS, Wippold FJ, Ozyigit G, Tran BN, Dempsey JF,. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 2002; 53: 1174-1184.
10. Studer G, Zwahlen RA, Graetz KW, Davis BJ, Glanzmann C,. IMRT in oral cavity cancer. Radiat Oncol 2007; 2: 16.
11. Yao M, Chang K, Funk GF, et al. The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapythe University of Iowa experience. Int J Radiat Oncol Biol Phys 2007; 67: 1332-1341.
12. Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA,. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003; 55: 312-321.
13. Daly ME, Lieskovsky Y, Pawlicki T, et al. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck 2007; 29: 211-220.
14. Bussels B, Maes A, Hermans R, Nuyts S, Weltens C, Van den Bogaert W,. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol 2004; 72: 119-127.
15. Schoenfeld GO, Amdur RJ, Morris CG, Li JG, Hinerman RW, Mendenhall WM,. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008; 71: 377-385.
16. Studer GM, Glanzmann, C., Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer: in regard to Schoenfeld et al (Int J Radiat Oncol Biol Phys 2008; 71: 377-385). Int J Radiat Oncol Biol Phys 2008; 72: 1271-1272; author reply 1272.
17. Grégoire V, Eisbruch A, Hamoir M, Levendag P,. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 2006; 79: 15-20.
18. Cerezo L, Martin M, Lõpez M, Marín A, Gõmez A,. Ipsilateral irradiation for well lateralized carcinomas of the oral cavity and oropharynx: results on tumor control and xerostomia. Radiat Oncol. 2009; 4: 33.
19. Chow TL, Chow TK, Chan TT, Yu NF, Fung SC, Lam SH,. Contralateral neck recurrence of squamous cell carcinoma of oral cavity and oropharynx. J Oral Maxillofac Surg 2004; 62: 1225-1228.
20. Kurita H, Koike T, Narikawa JN, et al. Clinical predictors for contralateral neck lymph node metastasis from unilateral squamous cell carcinoma in the oral cavity. Oral Oncol 2004; 40: 898-903.
21. Fakih AR, Rao RS, Borges AM, Patel AR,. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg 1989; 158: 309-313.
22. Chen TC, Wang CT, Ko JY, et al. Postoperative radiotherapy for primary early oral tongue cancer with pathologic N1 neck. Head Neck 2010; 32: 555-561.
23. Schiff BA, Roberts DB, El-Naggar A, Garden AS, Myers JN,. Selective vs modified radical neck dissection and postoperative radiotherapy vs observation in the treatment of squamous cell carcinoma of the oral tongue. Arch Otolaryngol Head Neck Surg 2005; 131: 874-878.
24. Brennan S, Corry J, Kleid S, et al. Prospective trial to evaluate staged neck dissection or elective neck radiotherapy in patients with CT-staged T1-2 N0 squamous cell carcinoma of the oral tongue. Head Neck 2010; 32: 191-198.
25. Sun LM, Leung SW, Su CY, Wang CJ,. The relapse patterns and outcome of postoperative recurrent tongue cancer. J Oral Maxillofac Surg 1997; 55: 827-831.
26. Lin CY, Lee LY, Huang SF, et al. Treatment outcome of combined modalities for buccal cancers: unilateral or bilateral neck radiation? Int J Radiat Oncol Biol Phys 2008; 70: 1373-1381.
27. O'Sullivan B, Warde P, Grice B, et al. The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys 2001; 51: 332-343.
28. Hinerman RW, Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB,. Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck 2004; 26: 984-994.
29. Seung S, Bae J, Solhjem M, et al. Intensity-modulated radiotherapy for head-and-neck cancer in the community setting. Int J Radiat Oncol Biol Phys 2008; 72: 1075-1081.
30. Monroe AT, Young JA, Huff JD, Ernster JA, White GA, Peddada AV,. Accelerated fractionation head and neck intensity-modulated radiation therapy and concurrent chemotherapy in the community setting: safety and efficacy considerations. Head Neck 2009; 31: 1144-1151.
31. Nangia S, Chufal KS, Tyagi A, Bhatnagar A, Mishra M, Ghosh D,. Selective nodal irradiation for head and neck cancer using intensity-modulated radiotherapy: application of RTOG consensus guidelines in routine clinical practice. Int J Radiat Oncol Biol Phys 2010; 76: 146-153.
32. Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004; 59: 28-42.
33. Cannon DM, Lee NY,. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008; 70: 660-665.